Mesenchymal stem cells (MSCs) are promising candidates for skin wound repair due to their capabilities of accumulating at wounds and differentiating into multiple types of skin cells. However, the underlying mechanisms responsible for these processes remain unclear. In this study, we found that osteopontin (OPN) stimulated the migration of MSCs in vitro, and observed the recruitment of endogenous MSCs to a skin wound and their differentiation into keratinocytes and endothelial cells. In OPN knock-out mice, the recruitment of MSCs to the skin wound was significantly inhibited, and wound closure was hampered after an intradermal injection of exogenous MSCs compared to wild-type mice. Consistent with these observations, the expressions of adhesion molecule CD44 and its receptor E-selectin were significantly decreased in the lesions of OPN knock-out mice compared with wild-type mice suggesting that OPN may regulate the migration of MSCs through its interactions with CD44 during skin wound recovery. In summary, our data demonstrated that OPN played a critical role in activating the migration of MSCs to injured sites and their differentiation into specific skin cell types during skin wound healing.
Introduction
Skin wound healing is a multi-stage process that orchestrates the reconstruction of dermal and epidermal layers. This process involves three overlapping phases, including the inflammatory, proliferation, and remodeling phases. Mesenchymal stem cells (MSCs) can differentiate into a variety of cell types, including osteoblasts, chondrocytes, adipocytes, myoblasts [1] endothelial cells [2, 3] , keratinocytes [2] neural cells [4, 5] , and hepatocytes [6, 7] in vitro. In vitro, MSCs can differentiate into tissue-specific cells in response to cues provided by different organs [8] MSCs could differentiate to endothelial cells, myofibroblasts and pericytes cells, promoting wound healing in vivo [2] . In addition, MSCs are also characterized by immunosuppressive effects on the surrounding environment after transplantation [9, 10] . MSCs have been used in clinical trials [11, 12] for the successful treatment of chronic wounds [13] MSCs are reported to be involved in all three phases [14] [15] [16] of skin wound healing. Osteopontin (OPN) is a glycosylated phosphoprotein. It can be found in body fluids and the extracellular matrix of mineralized tissues [17] .OPN responds to various stimulations such as inflammation, cellular stress, and injury and its expression increases during tumorigenesis and angiogenesis [18] [19] [20] [21] [22] . OPN can activate various signal pathways and modulate cellular activities [17, 23] by binding and interacting with specific cell surface receptors, including integrin and CD44 receptor variants [17, 24] .OPN can regulate cell migration, extracellular matrix (ECM) invasion, and cell adhesion in endothelial and epithelial cells through interactions with cell surface receptors [23, 25] OPN also plays a key role in the regulation of tissue remodeling [17] . It has been shown that the expression of OPN increases during wound healing, compared to healthy skin [26] . OPN knock-out (Opn -/-) mice show alterations in wound healing, including matrix disarrangement and modifications of collagen fibrillogenesis in the cartilage compared with their wild-type littermates [26] .
A previous study found that OPN expression was significantly up-regulated during wound healing, but little is known about its mechanisms [27] This paper shows that the expression of osteopontin increases in wounds, facilitating the mobilization of bone marrow derived stem cells into wounds by interacting with CD44. The accumulated MSCs at wound sites subsequently transdifferentiates into multiple skin cell types and contribute to wound repair. 
Materials and methods

Ethical statement
Differentiation of the MSCs into the mesenchymal lineage
For MSC differentiation, a 70% subconfluent culture of MSCs from the third passage were used. The MSCs were placed in basic medium, consisting of Dulbecco's modified Eagle's medium (DMEM) (Invitrogen Life Technologies), 10% fetal bovine serum (FBS), 1% penicillin, 1% streptomycin and 1% amphotericin B. Specific supplements were added to this basic medium formulation for the differentiation of the MSCs into various mesenchymal lineages [28] . Adipogenic differentiation was induced with 0.5 μM dexamethasone, 0.5 Mm 3-isobutyl-1-methylxanthine and 0.1 mM indomethacin (Sigma) [29] . Osteogenic differentiation was achieved with 0.1 μM of dexamethasone, 50 μM ascorbic acid and 10 mM-glycerophosphate (Sigma) [30] . Chondrogenic differentiation was induced with 50 μM ascorbic acid, 0.1 μM dexamethasone, 10 ng/ml transforming growth factor-beta (TGF-β) (R&D Systems), 40 μg/ml L-proline (Sigma-Aldrich) and 100 μg/ml sodium pyruvate (Wako) [31] . The differentiation medium was refreshed every 2 days. Differentiation into adipocytes, osteocytes and chondrocytes was confirmed by oil red O, von Kossa and toluidine blue staining, respectively [30] 
Differentiation of MSCs into keratinocytes
MSCs were cultured on 8-well glass slide chambers with keratinocyte basal medium (Invitrogen Life Technologies) containing 0.5 nM bone morphogenetic protein-4 (BMP-4) (SAB), 0.3 mM ascorbic acid and 3 ng/ml epidermal growth factor (Pepro Tech; Rocky Hill, U.S.A) [32] . The medium was changed every 2 days. After 17 days, the MSCs were stained with a keratin 14 (CK14) antibody (Abcam, ab7800, diluted 1:300).
Endothelial cell differentiation
Confluent MSCs cells were cultivated in the presence of 4% FBS, 50 ng/ml vascular endothelial growth factor (VEGF) (Pepro Tech; Rocky Hill, U.S.A), 10 ng/ml basic fibroblast growth factor (b-FGF) (Pepro Tech; Rocky Hill, U.S.A), 100U/ml penicillin and 100U/ml streptomycin for 12 days [33, 34] . Then the MSCs were stained with a von Willebrand factor (vWF) antibody (Abcam, ab11713, diluted 1:500). The medium was changed every 2 days.
In vitro angiogenesis
A capillary formation assay was performed strictly following the manufacturer's instructions and examined with an in vitro angiogenesis kit (Chemicon; Temecula, CA). A 50 μl gel matrix solution was applied to one well of a 96-well plate and incubated for 1 hour at 37˚C. The cells that differentiated into endothelial cells were then trypsinized, and 1x10 4 cells were resuspended in 100 μl of the endothelial medium, plated onto the gel matrix and cultured for 18 hours. The percentage of capillaries formed was calculated from three independent experiments.
Skin incisional wounding and a directed migration assay in vivo
Male wild-type C57BL/6 and Opn -/-mice (8-10 weeks old) were anesthetized, and full-thickness punch biopsy wounds of 5 mm in diameter were made on the animals' backs. A total of 5x10 5 wild-type GFP MSCs were intradermally injected 5 mm from the wounds. And injection of phosphate-buffered saline (PBS) at the wound periphery was performed as a control. Standardized images of the wounds were taken with a digital camera for daily wound size analyses. The next day after the invasive operation, the migration of MSCs was observed with a small animal in vivo imaging instrument (Xenogen IVIS spectrum, caliper, USA) and fluorescence was evaluated daily until the 7th day. Skin samples were collected at specific time points after wounding. For immunofluorescence staining, the skin samples were fixed in 4% paraformaldehyde and embedded in paraffin. A statistical analysis was performed using Student's t-test, with n = 6 animals per group.
Immunofluorescence staining
Skin sections were stained with an anti-GFP antibody. The skin sections were also treated with primary Abs against CD31 (Abcam, ab28364, diluted 1:300), vWF (Abcam, ab11713, diluted 1:300), CK14 (Abcam, ab7800, diluted 1:500), CD44 (Abcam, ab157107, diluted 1:400), Eselectin (Abcam, ab18981, diluted 1:400), Secondary antibodies conjugated to rhodamine-isothiocyanate were used for fluorescence detection on a confocal laser scanning fluorescence microscope (Zeiss, German).
Statistical analysis
The data are expressed as the means ± SD of the indicated number of observations. In all instances in which a radioisotope was used, background radioactivity was subtracted before quantifying radioactivity. Comparisons between two groups were performed using the unpaired, two-tailed Student's t-test. If necessary, a one-way analysis of variance (ANOVA) was applied for comparisons among multiple groups. In all cases, P values less than 0.05 were considered significant.
Results
Characterization of isolated MSCs
To characterize the isolated MSCs, flow cytometry was performed to analyze the expressions of cell surface markers of MSCs. The expressions of CD29, CD44, CD105 and Sca-1, but not CD34 and CD117, were positive in MSCs (Fig 1A) , which is consistent with previous reports [30, 35] . Moreover, MSCs were also evaluated for their differentiation ability to adipogenic, osteogenic, and chondrogenic cells. These cell types are positive for oil red O staining, von Kossa staining, and toluidine blue staining, indicating adipogenic, osteogenic, and chondrogenic cell type differentiation, respectively (Fig 1B-1D) . Only the cells that were consistent with these criteria were selected for our experiments.
Recombinant OPN promoted the migration of MSCs
The migration assay was performed using 24-well transwell chambers. The cells on the underside of the filters were detected and counted under a microscope 24 hours later. Images were taken randomly in four fields from each insert. The experiments showed that the number of migrated wild-type MSCs was greater than the number of migrated Opn -/-MSCs, and that the addition of rOPN increased the migration potential of the MSCs (Fig 2) .
The differentiation of MSCs into endothelial cells and keratinocytes were OPN-dependent
Endothelial cells and keratinocytes have very important roles in wound healing. To assess whether MSCs can trans-differentiate into these two cell types in vitro, wild-type and Opn -/-MSCs were exposed to endothelial and keratinocyte induction systems. At day 12 after differentiation, the expression of vWF, an endothelial-specific marker, was detected by immunofluorescence, and the expression of vWF in wild-type MSCs was higher than in Opn -/-MSCs ( Fig   3A and 3B) . The angiogenic capability of MSCs was assessed using an in vitro capillary formation assay. As shown in Fig 3C, capillary-like structures that originated from wild-type and Opn -/-MSCs were similar, but their total tube numbers were significantly different (Fig 3D) .
In addition, at day 17 after epithelial induction, the morphology of some cells had changed into the typical pebble-like shapes of epithelial cells, losing their original spindle-like-shapes (Fig 3E) . Furthermore, most of these pebble-like epithelial cells expressed the keratin 14 protein, an epithelial cell marker (Fig 3F and 3G) . wild-type GFP positive MSCs were injected directly into the wound site and 5 mm away from the wound, respectively. In vivo images were obtained from each mouse every day by the IVIS system. As shown in Fig 4, the GFP signal was detected from the first day after injection in wild-type mice and accumulated in the wounds from the third day on. Migration was greatest on the fifth day (Fig 4A and 4C) . In contrast, in Opn -/-mice, the GFP signal was obviously weaker, most likely because the cells had migrated elsewhere (Fig 4B and 4C) .
OPN leads to the differentiation of MSCs into multiple skin cell types
MSCs could differentiate into multiple skin cell types during wound healing [2] . To identify whether OPN regulates the differentiation of MSCs into skin cells during wound healing, wild-type GFP MSCs were injected into injured skin sites in wild-type and Opn -/-mice.
Wounded skin samples were harvested at indicated time points (the seventh day after injection) for immunofluorescence staining of skin cell markers. We found that GFP-positive cells were co-labeled with endothelial cell markers CD31 and vWF (Fig 5A and 5B ) and keratinocyte marker keratin 14 ( Fig 5C) . However, the number of GFP-positive cells in the wild-type mice was greater than in the Opn -/-mice, indicating that OPN recruited more MSCs to the wound sites in the wild-type mice. Moreover, the percentages of GFP and CD31, vWF or keratin 14 co-labeled cells were higher in the wild-type mice compared to the Opn -/-mice (Fig 5D-5F ). In addition, the expressions of CD31, vWF, and keratin 14 were higher in the wild-type mice compared to the Opn -/-mice.
OPN deficiency impedes wound healing in MSCs treatment of skin injury
We compared the wounds between wild-type and Opn -/-mice during the repair process. As shown in Fig 6B and 6C , treatment with MSCs by injection accelerated wound healing in the wild-type mice, but similar treatment result was not observed in the Opn -/-animals with the same MSCs administration. After MSCs treatment, the rate of wound healing in the wild-type mice was dramatically higher than in the Opn -/-mice at early time points (Fig 6B and 6C) , with a mean of 62.6% closure achieved by 3 d in the wild-type mice, which is significantly higher than 36.2% closure in the Opn -/-mice. The rate of wound healing in the wild-type MSCs group was higher than in the Opn -/-MSCs group at days 7 and 8, but there was no statistically significant difference between the two groups (Fig 6C) , possibly because the number of animals in each group was relatively small (6 mice per group).
CD44 and E-selectin expressions were down-regulated in Opn-/-mice
MSCs constitutively express the cell surface receptor CD44, which can interact with OPN to increase cell motility, invasion and angiogenesis [36, 37] As shown in Fig 7A and 7C , immunofluorescence staining showed that CD44 expression was attenuated in Opn -/-mice compared to wild-type mice, indicating that OPN/CD44 signaling may play a role in MSCmediated wound healing. CD44 is the ligand of E-selectin, which plays an important role in mediating tissue-specific T cells into skin and primitive hematopoietic progenitor cells (HPCs) into bone marrow (BM) [38] .To explore whether CD44 and E-selectin are involved in OPN-mediated wound healing, the expression of E-selectin was detected. As shown in Fig 7B and 7D , E-selectin expression was attenuated in Opn -/-mice compared with wild-type mice, suggesting that decreased Eselectin/CD44 expression was associated with OPN deficiency and contributed to the recruitment of MSCs to injured sites.
Discussion
MSCs represent a powerful tool for skin wound therapy, but the underlying mechanism remains unknown. In this paper, we showed that OPN promoted the activation of MSCs, including their migration and specific cell differentiation during skin wound healing and in vitro. MSCs derived from both wild-type and Opn -/-mice expressed keratin 14 and vWF after induction, with lower expression levels observed in the MSCs from the Opn -/-mice. In vivo,
MSCs could be recruited to wound sites and differentiate into multiple skin cell types including keratinocytes and endothelial cells, contributing to wound healing. More MSCs were recruited to the wound sites of the wild-type mice and exhibited higher differentiation efficiency compared to the Opn -/-mice. In addition, MSCs treatment by intradermal injection significantly accelerated wound closure in wild-type mice, but no similar treatment effect was observed in the Opn -/-mice. Finally, the expression of the adhesion molecule, CD44, increased in the skin lesions of the wild-type mice, compared to the Opn -/--mice. These data suggest that the OPN-CD44 pathway is involved in MSC-mediated skin wound healing. Chronic or refractory skin wounds are an ongoing challenge in wound care. TransplantedMSCs can differentiate into various cell lineages in wound sites and, provide immunomodulatory effects. Standal et al. demonstrated that OPN acted as a chemoattractant for a variety of cells types [39] , but whether it has any role in MSCs in skin wound healing remains undetermined. In this paper, we showed that MSCs migrated to wound sites in an OPN-dependent manner. To further validate this finding, GFP-positive MSCs were intradermally injected around wounds and a stronger GFP signal was detected in the skin wounds of wild-type mice than in the skin wounds of Opn -/-mice at day 3. These data confirm that OPN plays a critical role in the migration of MSCs to wounds. This paper confirms that MSCs could differentiate into keratinocytes and endothelial cells both in vitro and in vivo. However, OPN deficiency decreases the differentiation efficiency of MSCs indicating that OPN could stimulate specific skin cell differentiation in MSCs.
Cell migration involves a cascade of events initiated by shear-resistant adhesive interactions between flowing cells and the vascular endothelium at the target tissue [40] . The selectin family mediates leukocyte tethering and rolling interactions on endothelial cells. This paper shows that Opn -/-mice exhibit decreased CD44/E-selectin expression compared to wild-type mice, which may lower the efficiency of the tethering and rolling of MSCs on the endothelial surface. We speculate that OPN plays a key role in CD44/E-selectin-mediated MSCs rolling in the vascular endothelium. Taken together, our data demonstrate that trauma results in the up-regulation of OPN, thereby facilitating the mobilization of MSCs for wound healing. In addition, accumulating MSCs can transdifferentiate into multiple skin cell types in the wound, thus contributing to repair.
